Brosens N, Samouil D, Stolker S, Katsika E, Weggen S, Lucassen P
J Alzheimers Dis. 2023; 96(3):1097-1113.
PMID: 37980670
PMC: 10741326.
DOI: 10.3233/JAD-230727.
Cunliffe G, Lim Y, Chae W, Jung S
Biomedicines. 2022; 10(12).
PMID: 36551821
PMC: 9776382.
DOI: 10.3390/biomedicines10123064.
Chen R, Williams D, Nishimi K, Slopen N, Kubzansky L, Weuve J
Soc Sci Med. 2022; 314:115448.
PMID: 36274453
PMC: 10069937.
DOI: 10.1016/j.socscimed.2022.115448.
Pretscher A, Kauzner S, Rohleder N, Becker L
Eur J Ageing. 2021; 18(4):575-590.
PMID: 34786017
PMC: 8563879.
DOI: 10.1007/s10433-021-00616-8.
Huang V, Hogan D, Ismail Z, Maxwell C, Smith E, Callahan B
Can Geriatr J. 2020; 23(4):297-328.
PMID: 33282050
PMC: 7704078.
DOI: 10.5770/cgj.23.416.
Stress-Induced Neurodegeneration: The Potential for Coping as Neuroprotective Therapy.
Kline S, Mega M
Am J Alzheimers Dis Other Demen. 2020; 35:1533317520960873.
PMID: 32969239
PMC: 10623922.
DOI: 10.1177/1533317520960873.
Levels of Cortisol in CSF Are Associated With SNAP-25 and Tau Pathology but Not Amyloid-β.
Wang Q, Zhou W, Zhang J
Front Aging Neurosci. 2018; 10:383.
PMID: 30524269
PMC: 6256241.
DOI: 10.3389/fnagi.2018.00383.
Early Life Stress and Epigenetics in Late-onset Alzheimer's Dementia: A Systematic Review.
Lemche E
Curr Genomics. 2018; 19(7):522-602.
PMID: 30386171
PMC: 6194433.
DOI: 10.2174/1389202919666171229145156.
Vulnerability and resilience to Alzheimer's disease: early life conditions modulate neuropathology and determine cognitive reserve.
Lesuis S, Hoeijmakers L, Korosi A, de Rooij S, Swaab D, Kessels H
Alzheimers Res Ther. 2018; 10(1):95.
PMID: 30227888
PMC: 6145191.
DOI: 10.1186/s13195-018-0422-7.
A preclinical perspective on the enhanced vulnerability to Alzheimer's disease after early-life stress.
Hoeijmakers L, Lesuis S, Krugers H, Lucassen P, Korosi A
Neurobiol Stress. 2018; 8:172-185.
PMID: 29888312
PMC: 5991337.
DOI: 10.1016/j.ynstr.2018.02.003.
Targeting glucocorticoid receptors prevents the effects of early life stress on amyloid pathology and cognitive performance in APP/PS1 mice.
Lesuis S, Weggen S, Baches S, Lucassen P, Krugers H
Transl Psychiatry. 2018; 8(1):53.
PMID: 29491368
PMC: 5830444.
DOI: 10.1038/s41398-018-0101-2.
RCAN1 in the inverse association between Alzheimer's disease and cancer.
Fu Q, Wu Y
Oncotarget. 2018; 9(1):54-66.
PMID: 29416595
PMC: 5787488.
DOI: 10.18632/oncotarget.23094.
Targeting Neuroinflammation to Treat Alzheimer's Disease.
Ardura-Fabregat A, Boddeke E, Boza-Serrano A, Brioschi S, Castro-Gomez S, Ceyzeriat K
CNS Drugs. 2017; 31(12):1057-1082.
PMID: 29260466
PMC: 5747579.
DOI: 10.1007/s40263-017-0483-3.
Effects of stress hormones on the brain and cognition: Evidence from normal to pathological aging.
Souza-Talarico J, Marin M, Sindi S, Lupien S
Dement Neuropsychol. 2017; 5(1):8-16.
PMID: 29213714
PMC: 5619133.
DOI: 10.1590/S1980-57642011DN05010003.
Weather conditions: a neglected factor in human salivary cortisol research?.
Milas G, Supe-Domic D, Drmic-Hofman I, Rumora L, Martinovic Klaric I
Int J Biometeorol. 2017; 62(2):165-175.
PMID: 28884366
DOI: 10.1007/s00484-017-1436-8.
Stress induced neural reorganization: A conceptual framework linking depression and Alzheimer's disease.
Ross J, Gliebus G, Van Bockstaele E
Prog Neuropsychopharmacol Biol Psychiatry. 2017; 85:136-151.
PMID: 28803923
PMC: 5809232.
DOI: 10.1016/j.pnpbp.2017.08.004.
Associations between Sleep, Cortisol Regulation, and Diet: Possible Implications for the Risk of Alzheimer Disease.
Pistollato F, Sumalla Cano S, Elio I, Vergara M, Giampieri F, Battino M
Adv Nutr. 2016; 7(4):679-89.
PMID: 27422503
PMC: 4942871.
DOI: 10.3945/an.115.011775.
Aberrant expression of RCAN1 in Alzheimer's pathogenesis: a new molecular mechanism and a novel drug target.
Wu Y, Ly P, Song W
Mol Neurobiol. 2014; 50(3):1085-97.
PMID: 24752590
DOI: 10.1007/s12035-014-8704-y.
Basal functioning of the hypothalamic-pituitary-adrenal (HPA) axis and psychological distress in recreational ecstasy polydrug users.
Wetherell M, Montgomery C
Psychopharmacology (Berl). 2013; 231(7):1365-75.
PMID: 24190587
DOI: 10.1007/s00213-013-3325-0.
Effects of anosognosia on perceived stress and cortisol levels in Alzheimer's disease.
Arsenault-Lapierre G, Whitehead V, Lupien S, Chertkow H
Int J Alzheimers Dis. 2012; 2012:209570.
PMID: 22500245
PMC: 3303539.
DOI: 10.1155/2012/209570.